Oligonucleotides—A Novel Promising Therapeutic Option for IBD
Sign Up to like & getrecommendations! Published in 2019 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2019.00314
Abstract: Inflammatory Bowel Diseases (IBD), whose denomination comprehends Crohn's Disease (CD) and Ulcerative Colitis (UC), are intestinal chronic diseases that often require lifelong medical therapy. In the last two decades monoclonal antibodies against the cytokine TNF… read more here.
Keywords: oligonucleotides novel; novel promising; efficacy; therapeutic option ... See more keywords